Fusing Omics and Advanced Cell Models: A New Era for Drug Discovery and Reproducibility
July 10, 2025, at 12:00 PM ETAbstract
The way we discover and develop new therapies is changing—fast. Thanks to advances in omics technologies and newer cell models that closely recapitulate primary cells and tissue, researchers now have powerful tools to better understand biology and disease. In this webinar, we’ll explore how combining omics data—like genomics, and transcriptomics, and proteomics—with cutting-edge 2-D and 3-D cell models is opening new doors in drug discovery and helping to tackle the long-standing challenge of reproducibility. Join us as we dive into real-world examples, share emerging tools, and discuss how these integrated approaches are making research more predictive, more reliable, and ultimately more impactful.
Key Points
- See more, know more—learn how combining omics with advanced cell models gives richer insights into biology and disease.
- Make results stick—discover how these models boost reproducibility and reduce variability across studies.
- Move faster, smarter—explore how this approach speeds up discovery and brings better therapies closer to the clinic.
Presenters
Ajeet Singh, PhD
Senior Scientist, ATCC
Dr. Ajeet Singh is Senior Scientist at ATCC where he is focused on providing reference-grade whole transcriptome data that is authenticated, standard, and traceable to physical source materials available in ATCC’s biorepository. Prior to joining ATCC, Dr. Singh received his PhD in Agricultural Plant Pathology where he performed research focused on epidemiology and integrated management of plants pests and diseases. He then performed postdoctoral research at the National Institute of Environmental Health Sciences and subsequently worked as a Senior Staff Scientist at the National Cancer Institute. Dr. Singh has extensive experience in biomedical research with his research career expanding an array of interrelated disciplines exploring epigenetics, chromatin and gene expression in reproductive developmental toxicology, stem cell biology, and cancer.
Hrisavgi Kondilis-Mangum
Senior Manager, QDI Professional Services, QIAGEN
Hrisavgi Kondilis-Mangum is the product manager for the ATCC Cell Line Land and a manager within the QIAGEN Digital Insights Professional Services team. As a molecular immunologist, Hrisavgi helps bridge the gap between bench scientists and bioinformaticians/data scientists. Her years preparing immune cell samples for NGS and other assays has followed her into helping create structured data with the right content in a big data setting. Hrisavgi earned a doctor of philosophy degree in immunology at Duke University, where her research focused on the role of epigenetics in regulating V(D)J recombination and allelic exclusion.
Kristin O’Malley, BS
Senior Field Application Scientist, QIAGEN Digital Insights, QIAGEN
Kristin O’Malley has spent much of her career at the bench in genomics labs in the clinical space, large pharmaceutical companies, and small start up biotechs. She took this experience and switched gears a few years ago to become a field application scientist. She enjoys the broad spectrum of biology she encounters and empowering scientists to be successful in their own endeavors. Kristin received a Bachelor of Science education from Worcester State University.
